🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ryosuke Imai

Japan Tobacco (United States)

ORCID: 0000-0002-3129-916X

Also affiliated with St. Luke's International Hospital, Japan Tobacco (Japan), IncSys (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Association of Anti-Ro52 Seropositive Interstitial Lung Disease With a Higher Risk of Disease Progression and Mortality”.

Association of Anti-Ro52 Seropositive Interstitial Lung Disease With a Higher Risk of Disease Progression and Mortality

CHEST Journal(2025)10.1016/j.chest.2025.05.036

N/A

0DataRank · unranked

12 citations

Rene S. Bermea, Sophia H. Zhao, Sydney B. Montesi, Anjali Singh, B. Flashner +7 more

Anti-Mi-2 positive interstitial lung disease (ILD): A progressive disease comparable to other myositis-ILD

Respiratory Medicine and Research(2025)10.1016/j.resmer.2025.101176

N/A

0DataRank · unranked

1 citations

Ryosuke Imai, A. Synn, J. Munchel, Lida P. Hariri, Fiona K. Gibbons +6 more

Progressive course of anti-nuclear matrix protein-2 (NXP-2) positive-interstitial lung disease

Respiratory Medicine and Research(2025)10.1016/j.resmer.2025.101170

N/A

0DataRank · unranked

0 citations

Ryosuke Imai, A. Synn, J. Munchel, Lida P. Hariri, Fiona K. Gibbons +6 more